Apolipoprotein A-IV-2 allele: Association of its worldwide distribution with adult persistence of lactase and speculation on its function and origin

Genetic Epidemiology

Volumn 17, Issue 4, 1999, Pages 285-297

  Weinberg, Richard B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein A IV; Apolipoprotein E; Atherosclerosis; Genetic polymorphisms; Lactase; Lactose intolerance; Milk; Population genetics

Indexed keywords

APOLIPOPROTEIN A4; LACTASE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; ENZYME SYNTHESIS; FAT INTAKE; GENE FREQUENCY; GENETIC RISK; GEOGRAPHIC DISTRIBUTION; HUMAN; INTESTINE ABSORPTION; LIPID ABSORPTION; MAJOR CLINICAL STUDY; MILK INTOLERANCE; RACE DIFFERENCE;

ALLELES; APOLIPOPROTEINS A; BETA-GALACTOSIDASE; EUROPE; HUMANS; ICELAND; LACTASE; LACTOSE INTOLERANCE; POLYMORPHISM, GENETIC; POPULATION SURVEILLANCE; PREVALENCE;

EID: 0032736985     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2272(199911)17:4<285::AID-GEPI4>3.0.CO;2-3     Document Type: Article

References (78)

1. Akiyama K. 1989. Population study of apolipoprotein A-IV polymorphism and report of a new variant in Japanese. Hum Hered 39:302-304.
2. Asakawa J, Takahashi N, Rosenblum BB, Neel JV. 1985. Two dimensional gel studies of genetic variation in the plasma proteins of Amerindians and Japanese. Hum Genet 70:222-230.
3. Bai H, Saku K, Liu R, Funke H, Von Eckardstein A, Arakawa K. 1993. Polymorphic site study at codon 347 of apolipoprotein A-IV in a Japanese population. Biochim Biophys Acta 1174:279-281.
4. Bai H, Saku K, Liu R, Oribe Y, Yamamoto K, Arakawa K. 1996. Polymorphisms of the apolipoprotein A-IV gene and its significance in lipid metabolism. Eur J Clin Invest 26:1115-1124.
5. Boerwinkle E, Sing CF. 1986. Roles of the apolipoprotein E and A-IV polymorphism in determining plasma lipid and apolipoprotein levels. 7th International Congress of Human Genetics, Berlin, Part II:751-752 (abstr).
6. Braekman L, De Bacquer D, Rosseneu M, De Backer G. 1996. Apolipoprotein E polymorphism in middle-aged Belgian men: phenotype distribution and relation to serum lipids and lipoproteins. Atherosclerosis 120:67-73.
7. Campos H, Lopez-Miranda J, Rodrigquez C, Albajar M, Schaefer EJ, Ordovas JM. 1997. Urbanization elicits a more atherogenic lipoprotein profile in carriers of the apolipoprotein A-IV-2 allele than in apo A-IV-1 homozygotes. Arteriosclerosis Throm Vasc Biol 17:1074-1081.
8. Carrejo MH, Sharrett R, Patsch W, Boerwinkle E. 1995. No association of apolipoprotein A-IV codon 347 and 360 variation with atherosclerosis and lipid transport in a sample of mixed hyperlipidemics. Genet Epidemiol 12:371-380.
9. Crews DE, Kamboh MI, Bindon JR, Ferrell RE. 1991. Genetic studies of human apolipoproteins. XVII: Population genetics of apolipoprotein polymorphisms in American Samoa. Am J Phys Anthropol 84:165-170.
10. Crews DE, MI Kamboh, Manchila-Carvalho, Kottke B. 1993. Population genetics of apolipoprotein A-4, E, and H polymorphisms in the Yanomami Indians of northwestern Brazil: associations with lipids, lipoproteins, and carbohydrate metabolism. Hum Biol 65:211-224.
11. Csaszar A, Kalma J, Szalai C, Janka Z, Romics L. 1997. Association of the apolipoprotein A-IV codon 360 mutation in patients with Alzheimer's disease. Neurosci Lett 230:151-154.
12. de Knijff P, Rosseneu M, Beisiegel U, de Keersgieter W, Frants RR, Havekes LM. 1988. Apolipoprotein A-IV polymorphism and its effects on plasma lipid and apolipoprotein concentrations. J Lipid Res 29:1621-1627.
13. de Kniff P, Johansen LG, Rosseneu M, Frants RR, Jespersen J, Haekes LM. 1992. Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, apo E and A4 polymorphism, and lifestyle. Arterioscler Thromb 12:1371-1379.
14. Ehnholm C, Tenkanen H, de Knijff P, Havekes L, Rosseneu M, Menzel HJ, Tiret L. 1994. Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: the EARS study. Atherosclerosis 107: 229-238.
15. Eichner JE, Kuller LH, Ferrell RE, Kamboh MI. 1989. Phenotypic effects of apolipoprotein structural variation on lipid profiles. IV. Apolipoprotein polymorphisms in a small group of black women from the healthy women study. Genet Epidemiol 6:681-689.
16. Flatz G. 1987. Genetics of lactose digestion in humans. Adv Hum Genet 16:1-77.
17. Gerdes LU, Klausen IC, Sihm I, Faergeman O. 1992. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Gent Epidemiol 9:155-167.
18. Green PH, Glickman RM, Saudek CD, Blum CB, Tall AR. 1979. Human intestinal lipoproteins: studies in chyluric subjects. J Clin Invest 64:233-242.
19. Green PH, Glickman RM, Riley JW, Quinet E. 1980. Human apolipoprotein A-IV: intestinal origin and distribution in plasma. J Clin Invest 65:911-919.
20. Halleman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, Utermann G. 1993. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 49: 338-349.
21. Hanis CL, Douglas TC, Hewett-Emmett D. 1991. Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins and apolipoproteins among Mexican-Americans in Starr County, Texas. Hum Genet 86:323-325.
22. Hockey KJ, Anderson RA, Weinberg RB. 1998. Effect of the variant apolipoprotein allele A-IV-2 on post-prandial plasma lipid clearance. Gastroenterology 114:A1256.
23. Kalogeris TJ, Rodriquez MD, Tso P. 1997. Control of synthesis and secretion of intestinal apolipoprotein A-IV. J Nutr 127:537S-543S.
24. Kamboh MI, Ferrell RE. 1987. Genetic studies of human apolipoproteins I. Polymorphism of apolipoprotein A-IV. Am J Hum Genet 41:119-127.
25. Kamboh MI, Ferrell RE. 1990. Genetic studies of human apolipoproteins. XVI: An overview of IEF immunoblotting methods to screen apolipoprotein polymorphisms. Hum Hered 40:193-207.
26. Kamboh MI, Bhatia KK, Ferrell RE. 1990. Genetic studies of human apolipoproteins: XII. Population genetics of apolipoproteins in Papua New Guinea. Am J Hum Biol 2:17-32.
27. Kamboh MI, Serjeantson SW, Ferrell RE. 1991a. Genetic studies of human apolipoproteins. XVIII: Apolipoprotein polymorphisms in Australian Aborigines. Hum Biol 63:179-186.
28. Kamboh MI, Hamman RF, Iyengar S, Aston CE, Ferrell RE. 1991b. Apolipoprotein A-IV polymorphism, and its role in determining variation in lipoprotein lipid, glucose and insulin levels in normal and non-insulin-dependent diabetic individuals. Atherosclerosis 91:25-34.
29. Kamboh MI, Weiss KM, Ferrell RE. 1991c. Genetic studies of human apolipoproteins: XVI. Apo E polymorphism and cholesterol levels in the Mayans of the Yucatan peninsula, Mexico. Clin Genet 39:26-32.
30. Kamboh MI, Haman RF, Ferrell RE. 1992a. Two common polymorphisms in the apo A-IV coding gene: their evolution and linkage disequilibrium. Genet Epidemiol 9:305-315.
31. Kamboh MI, Iyengar S, Aston CE, Hamman RF, Ferrell RE. 1992b. Apolipoprotein A-IV genetic polymorphism and its impact on quantitative traits in normoglycemic and non-insulin-dependent diabetic Hispanics from San Luis Valley, Colorado. Hum Biol 64:605-616.
32. Kamboh MI, Williams ER, Law JC, Aston CE, Bunker CH, Ferrell RE, Pollitzer WS. 1992c. Molecular basis of a unique African variant (A-IV-5) of human apolipoprotein A-IV and its significance in lipid metabolism. Genet Epidemiol 9:379-388.
33. Kamboh MI, Friedlander JS, Ahn YI, Ferrell RE. 1994. A common deletion polymorphism in the apolipoprotein A-IV gene and its significance in lipid metabolism. Arterioscler Thromb 14: 656-662.
34. Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. 1991. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 11:1330-1348.
35. Karathanasis SK. 1985. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc Natl Acad Sci USA 82:6374-6378.
36. Lehtimaki T, Uiba T, Roto P, Koivula T, Jokela H, Ehnholm C, Peltonen N, Nikkari T. 1998. Apolipoprotein E and A-IV polymorphisms in the Estonian population. Clin Genet 54:106-107.
37. Leis R, Tojo R, Pilar P, Douwes A. 1997. Prevalence of lactose malabsorption in Galicia. J Ped Gastro Nutr 25:296-300.
38. Lohse P, Brewer HB. 1991. Genetic polymorphism of apolipoprotein A-IV. Curr Opin Lipid 2:90-95.
39. Lohse P, Kindt MR, Rader DJ, Brewer HB. 1990. Genetic polymorphism of human apolipoprotein A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene. J Biol Chem 265:10061-10064.
40. Lohse P, Kindt MR, Rader DJ, Brewer HB. 1991. Three genetic variants of apolipoprotein A-IV. J Biol Chem 266:13513-13518.
41. Lucotte G, Loirat F, Hazout S. 1997. Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe. Hum Biol 69:253-262.
42. Lukka M, Metso J, Enholm C. 1988. Apolipoprotein A-IV polymorphism in the Finnish population: gene frequencies and description of a rare allele. Hum Hered 38:359-362.
43. Luo CC, Li WH, Moore MN, Chan L. 1986. Structure and evolution of the apolipoprotein muitigene family. J Mol Biol 187:325-340.
44. Malle E, Pfeiffer KP, Dugi K, Pfeiffer C, Glaum M, Oezcueruemez K, Kloer HU, Steinmetz A. 1996. Polymorphisms of apolipoproteins A-IV and E in a Turkish population living in Germany. Hum Genet 98:285-290.
45. Mata P, Ordovas JM, Lopez-Miranda J, Lichtenstein AH, Clevidence B, Judd JT, Schaefer EJ. 1994. Apo A-IV phenotype affects diet-induced plasma LDL cholesterol lowering. Arterioscler Thromb 14:884-891.
46. McCombs RJ, Marcadis DE, Ellis J, Weinberg RB. 1994. Attenuated hypercholesterolemic response to a high cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N Engl J Med 331:706-710.
47. Menzel HJ, Kovary PM, Assmann G. 1982. Apolipoprotein A-IV polymorphism in man. Hum Genet 62:349-352.
48. Menzel HJ, Boerwinkle E, Schrangl-Will S, Utermann G. 1988. Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet 79:368-372.
49. Menzel HJ, Sigursson G, Boerwinkle E, Schrangl-Will S, Dieplinger H, Utermann G. 1990. Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum Genet 84:344-346.
50. Menzel HJ, Dieplinger H, Sandholzer C, Karadi I, Utermann G, Csaszer A. 1995. Apolipoprotein A-IV polymorphism in the Hungarian population: gene frequencies, effect on lipid levels, and sequence of two new variants. Hum Mutat 5:58-65.
51. Neville MC, Picciano MF. 1997. Regulation of milk lipid secretion and composition. Annu Rev Nutr 17:159-184.
52. Ordovas JM, Lopez-Miranda J, Perez-Jimenez F, Rodriguez C, Park JS, Cole T, Schaefer EJ. 1995. Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response of HMG CoA reductase inhibitor therapy. Atherosclerosis 113:157-166.
53. Pepe G, DiPerna V, Resta F, Lovecchio M, Chimienti G, Colacicco AM, Capurso A. 1998. In search of a biological pattern for human longevity: Impact of apo A-IV genetic polymorphisms on lipoproteins and the hyper-Lp(a. in centarians. Atherosclerosis 137:404-417.
54. Poser CM. 1995. Viking Voyages: the origin of multiple sclerosis? An essay in medical history. Acta Neurol Scand 161(Suppl):11-22.
55. Rader DJ, Schafer J, Lohse P, Verges B, Kindt M, Zech LA, Steinmetz A, Brewer HB. 1993. Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of apo A-IV-2 isoprotein. J Clin Invest 92:1009-1017.
56. Rewers M, Kamboh MI, Hoag S, Shetterly SM, Ferrell RE, Hamman RF. 1994. Apo A-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Study. Diabetes 43:1485-1489.
57. Rodriguez JC, Recalde D, Anibarro C, Albajar M, Cenarro A, Pocovi M. 1997. Polymorphims in the human apolipoprotein AIV gene detected by PCR and heteroduplex analysis. Atherosclerosis 134:81-82.
58. Saha N. 1991. Apolipoprotein A-IV polymorphism in Singapore ethnic groups. Hum Hered 41:47-52.
59. Saha N, Wang G, Vasisht S, Kamboh MI. 1997. Influence of two apo A4 polymorphisms at codons 347 and 360 on non-fasting plasma lipoprotein-lipids and apolipoproteins in Asian Indians. Atheroslcerosis 131:249-255.
60. Sahi T. 1994. Genetics and epidemiology of adult-type hypolactasia. Scand J Gastroenterol 29 suppl 202:7-20.
61. Schamaun O, Olaisen B, Teusberg P, Gedde-Dahl T, Ehnholm C. 1985. Genetic studies of apolipoprotein A-IV by two-dimensional electrophoresis. In: Peeters H, editor. Protides of the biological fluids, Vol 33. New York: Pergamon. p 471-474.
62. Scrimshaw NS, Murray EB. 1988. Prevalence of lactose malabsorption. Am J Clin Nutr 48:1079-1159.
63. Sepehrnia B, Kamboh MI, Adams-Campbell LL, Nwankwo M, Ferrell RE. 1988. Genetic studies of human apolipoproteins. VII. Population distribution of polymorphisms of apolipoproteins A-I, A-I, A-IV, C-II, E, and H in Nigeria. Am J Hum Genet 43:847-853.
64. Simoons FJ. 1978. The geographic hypothesis and lactose malabsorption. Digest Dis 23:963-980.
65. Tenkanen H, Koskinen P, Metso J, Baumann M, Lukka M, Kauppinen-Makelin R, Kontula , Taskinen MR, Manttari M, Manninen V, Ehnholm C. 1992. A novel polymorphism of apolipoprotein A-IV is the result of an asparagine to serine substitution at residue 127. Biochim Biophys Acta 1138:27-33.
66. Tiret L, De Kniff P, Menzel HJ, Ehnholm C, Nicaud V, Haeveks LM. 1994. Apo E polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS study. Arterioscler Thromb 14:1617-1624.
67. USDA nutrient database for standard reference. Release 10, July 1993. Washington, DC: Human Nutrition Information Service.
68. Verges BL, Vaillant G, Goux A, Lagrost L, Brun JM, Gambert P. 1994. Apolipoprotein A-IV levels and phenotype distribution in NIDDM. Diabetes Care 17:810-817.
69. Visvikis S, Steinmetz J, Boerwinkle, Gueguen R, Galteau MM, Siest G. 1989. Frequency and effects of the apolipoprotein A-IV polymorphism. Clin Genet 36:435-441.
70. Von Eckardstein A, Funke H, Schulte M, Erren M, Schulte H, Assmann G. 1992. Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B-and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet 50:1115-1128.
71. Von Eckardstein A, Heinrich J, Funke H, Schulte M, Shoenfeld R, Kohler E, Steinmetz A, Assmann G. 1993. Glutamine/histidine polymorphism in apolipoprotein A-IV affects plasma concentrations of lipoprotein(a) and fibrin split products in coronary heart disease patients. Arterioscler Thromb 13:240-246.
72. Von Eckardstein A, Funke H, Chirazi A, Chen-Haudenschild C, Schulte H, Schonfeld R, Kohler E, Schwarz S, Steinmetz A, Assmann G. 1994. Sex-specific effects of the glutamine/histidine polymorphism in apo A-IV on HDL metabolism. Arterioscler Thromb 14:1114-1120.
73. Wang Y, Harvey CB, Pratt WS, Sams VR, Sarner M, Rossi M, Auricchio S, Swallow DM. 1995. The lactase persistence/non-persistence polymorphism is controlled by a cis-acting element. Hum Mol Genet 4:657-662.
74. Weinberg RB, Scanu AM. 1983. The isolation and characterization of human apolipoprotein A-IV from lipoprotein depleted serum. J Lipid Res 24:52-59.
75. Weinberg RB, Jordan M, Steinmetz A. 1990. Distinctive structure and function of human apolipoprotein variant, Apo A-IV-2. J Biol Chem 265:18372-18378.
76. Weisgraber KH, Bersot TP, Mahley RW. 1978. Isolation and characterization of an apoprotein from the d<1.006 lipoproteins of human and canine lymph homologous with the rat A-IV apoprotein. Biochem Biophys Res Commun 85:287-292.
77. Zaiou M, Visvkis S, Visvikis A, Siest G. 1992. A rapid and reliable method for direct genotyping of codon 360 in the human apolipoprotein A-IV gene. J Lipid Res 33:1061-1066.
78. Zaiou M, Visvikis S, Gueguen R, Parra HJ, Fruchart JC, Siest G. 1994. DNA polymorphisms of human apolipoprotein A-IV gene: frequencies and effects on lipid, lipoprotein and apolipoprotein levels in a French population. Clin Genet 46:248-254.